4.0 Article

Validation of the Microlife WatchBP O3 device for clinic, home, and ambulatory blood pressure measurement, according to the International Protocol

Journal

BLOOD PRESSURE MONITORING
Volume 15, Issue 1, Pages 59-62

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MBP.0b013e32833531ca

Keywords

ambulatory blood pressure; device; hypertension; self measurement; validation

Funding

  1. Microlife WatchBP AG, Espenstrasee 139, CH 9443, Widnau, Switzerland

Ask authors/readers for more resources

To determine the accuracy of the Microlife WatchBP O3 blood pressure measuring device tested according to the requirements of the International Protocol of the European Society of Hypertension. The WatchBP O3 is designed to provide clinic, ambulatory, and self blood pressure (BP) measurements. Device evaluation was performed in 33 participants with a mean +/- standard deviation age of 56.1 +/- 20.7 years (range 30-95 years). Their systolic BP (SBP) was 144.7 +/- 24.1 mmHg (range 90-180 mmHg), diastolic BP (DBP) was 86.8 +/- 18.3 mmHg (range 50-120 mmHg), and arm circumference was 28.1 +/- 2.9 cm (range 22.0-34.0 cm). Blood pressure measurements were performed in the sitting position. The WatchBP 03 passed all three phases of the European Society of Hypertension protocol for SBP and DBP. Mean blood pressure differences for the WatchBP 03 (device observer) were -1.7 +/- 6.9 mmHg for SBP and -1.1 +/- 4.3 mmHg for DBP. In conclusion, these results indicate that the Microlife WatchBP 03 monitor can be recommended for clinical use in the adult population. Blood Press Monit 15:59-62 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available